Adial Pharmaceuticals(ADIL) - 2018 Q4 - Annual Report
Adial Pharmaceuticals(ADIL)2019-02-19 22:30
The NASDAQ Stock Market LLC The NASDAQ Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-3823 ADIAL PHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in Its Charter) S ...